8 completed, 1 active not recruiting, 1 not yet recruiting, 1 withdrawn. 11 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 11 | Completed 8, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1 |
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
Follow Leishmaniasis, Cutaneous: new trials by email Literature Review of Leishmaniasis, Cutaneous trials Research Report on Leishmaniasis, Cutaneous
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis MILTEFOSINE gel - Cutaneous Leishmaniasis, Cutaneous Leishmaniasis, American | Phase 1 | Not yet recruiting | Universidad Industrial de Santander | 15 | 2026-01-01 | 2025-09-08 |
| Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis Arnica Tincture - Leishmaniasis, Cutaneous | Phase 1 | Active not recruiting | Universidad de Antioquia | 16 | 2023-05-03 | 2025-02-10 |
| Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis. Experimental topical (Curaleish Topical) - Leishmaniasis, Cutaneous | Phase 1 / Phase 2 | Withdrawn | Universidad de Antioquia | 2021-01-01 | 2022-06-03 | |
| Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects DNDI-0690, Placebo of DNDI-0690 - Visceral Leishmaniasis, Cutaneous Leishmaniases | Phase 1 | Completed | Drugs for Neglected Diseases | 64 | 2019-04-04 | 2022-12-20 |
| Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly Liposomal amphotericin B (AmBisome®) - Cutaneous Leishmaniasis, American | Phase 1 / Phase 2 | Completed | Hospital Universitário Professor Edgard Santos | 28 | 2019-03-01 | 2024-06-07 |
| Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis. Sm29 Protein, Schistosoma Mansoni, Pentavalent antimony (Sbv) - Cutaneous Leishmaniasis, American | Phase 1 / Phase 2 | Completed | Hospital Universitário Professor Edgard Santos | 20 | 2019-01-17 | 2023-08-21 |
| Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia Topical Amphotericin B at 3% - Cutaneous Leishmaniasis | Phase 1 / Phase 2 | Completed | Drugs for Neglected Diseases | 80 | 2014-02-01 | 2016-07-26 |
| Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite Leish-111f + MPL-SE vaccine - Cutaneous Leishmaniasis | Phase 1 | Completed | Access to Advanced Health Institute (AAHI) | 12 | 2005-08-01 | 2006-05-05 |
| Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis Leish-111f + MPL-SE vaccine - Leishmaniasis, Cutaneous | Phase 1 | Completed | Access to Advanced Health Institute (AAHI) | 45 | 2004-10-01 | 2007-02-15 |
| Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis Leish-111f + MPL-SE vaccine - Leishmaniasis, Mucocutaneous | Phase 1 | Completed | Access to Advanced Health Institute (AAHI) | 48 | 2004-07-01 | 2007-02-15 |
| Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants Combination of autoclaved leishmania antigen with recombinant human interleukin-12 (rhIL-12) and aluminum hydroxide gel as adjuvants - Cutaneous Leishmaniasis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 50 | 1999-04-01 | 2008-03-04 |
Leishmaniasis (5) · Leishmaniasis, Mucocutaneous (4) · Leishmaniasis, Visceral (1) · Parasitic Diseases (1)
Euglenozoa Infections (11) · Infections (11) · Protozoan Infections (11) · Skin Diseases (11) · Skin Diseases, Infectious (11) · Skin Diseases, Parasitic (11) · Skin and Connective Tissue Diseases (11) · Vector Borne Diseases (11) · Parasitic Diseases (10) · Leishmaniasis (6)
Arnicae flos extract (1) · Interleukin-12 (1) · Sm29 protein, Schistosoma mansoni (1) · Solutions (1) · liposomal amphotericin B (1) · miltefosine (1)
Access to Advanced Health Institute (AAHI) (3) · Drugs for Neglected Diseases (2) · Hospital Universitário Professor Edgard Santos (2) · Universidad de Antioquia (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Universidad Industrial de Santander (1)
Colombia (5) · Brazil (3) · Peru (1) · United Kingdom (1) · United States (1)
Alejandro Llanos-Cuentas, MD (1) · Cristian Blanco, PhD (1) · Evaldo Nascimento, MD (1) · Franco M Piazza, MD, MPH (1) · Franco M Piazza, MD, MPh (1) · Ivan D Velez (1) · Ivan D Velez, PhD (1) · Ivan Dario Velez, Prof (1) · Sharan Sidhu, MD (1)
PMID 11353640, PMID 20851080, PMID 30044792, PMID 30815688, PMID 39147194, PMID 40825042
2018 (1)